ClearPoint Neuro, Inc. Operating Income Loss

• ClearPoint Neuro, Inc. showed a decrease of -22.4% in Operating Income Loss from 2024 to 2025.
• This data is from ClearPoint Neuro, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 16 years of available data (2010 to 2025), ClearPoint Neuro, Inc.'s Operating Income Loss has declined by 153.9%.
• Historical annual values: Fiscal year 2025: -$24.16 million | Fiscal year 2024: -$19.73 million | Fiscal year 2023: -$22.45 million | Fiscal year 2022: -$16.33 million | Fiscal year 2021: -$13.37 million | Fiscal year 2020: -$6.22 million | Fiscal year 2019: -$4.59 million | Fiscal year 2018: -$5.25 million | Fiscal year 2017: -$6.34 million | Fiscal year 2016: -$7.49 million | Fiscal year 2015: -$8.97 million | Fiscal year 2014: -$5.32 million | Fiscal year 2013: -$7.47 million | Fiscal year 2012: -$3.13 million | Fiscal year 2011: -$5.92 million | Fiscal year 2010: -$9.52 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026